Evid Invest
Who owns BCTXWhat BCTX owns — n/a

Who owns BriaCell Therapeutics Corp.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.

Institutional ownership of BCTX from SEC Form 13F filings across 13 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-06-30 reporting period, 13 institutions disclosed 188,762 shares of BriaCell Therapeutics Corp. worth $498,622 — about 2.6% of shares outstanding; the largest disclosed holder is IRIDIAN ASSET MANAGEMENT LLC/CT. Source: SEC Form 13F filings, parsed by EvidInvest.

13

13F holders

$498,622

value, 2026 filers

2.6%

of shares outstanding (188,762 sh)

2

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of BCTX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1IRIDIAN ASSET MANAGEMENT LLC/CT65,000$210,6000.1%0.9%0.0%
2UBS Group AG43,642$141,4000.0%0.6%+278.1%
3HRT FINANCIAL LPNEW34,904$1130.0%0.5%new
4JANE STREET GROUP, LLCNEW26,515$85,9090.0%0.4%new
5LuminArx Capital Management LP15,000$48,6000.0%0.2%0.0%
6NATIONAL BANK OF CANADA /FI/1,803$5,7960.0%0%+124.8%
7MORGAN STANLEY1,033$3,3470.0%0%-65.8%
8Federation des caisses Desjardins du Quebec450$1,4440.0%0%-1.1%
9ROYAL BANK OF CANADA289$1,0000.0%0%+189.0%
10Allworth Financial LP100$3240.0%0%0.0%
11TD Waterhouse Canada Inc.19$660.0%0%0.0%
12HHM Wealth Advisors, LLC6$200.0%0%0.0%
13WELLS FARGO & COMPANY/MN1$30.0%0%0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.